Immunization News and Research

RSS

Specific immune therapy works for many people with allergies

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.

11 Jun 2008

Kaiser Permanente, Microsoft launch personal electronic health records pilot program

Officials from Kaiser Permanente and Microsoft on Monday announced that the companies are developing a patient information exchange pilot program, Reuters/Washington Post reports (Kaufman, Reuters/Washington Post, 6/9).

10 Jun 2008

Novel replacement for conventional needle and syringe

Chris Holden (21), A third year design student at Northumbria University, has won a prestigious national award for medical design by redesigning the conventional needle and syringe.

30 May 2008

US$28 million needed for Myanmar says WHO

WHO and its Health Cluster partners in Myanmar have launched a six-month and US$ 28 million action plan to provide immediate health care for cyclone survivors and to support longer-term efforts to rebuild the country's ravaged health system.

30 May 2008

Primate model for autism

A primate model for autism using the U.S. children's immunization schedule was unveiled at the International Meeting For Autism Research (IMFAR) this weekend.

20 May 2008

Getting sick in Victoria could be a worry

In what will be great concern to Australians living in Victoria, a newly released report has found that Victoria's hospitals have failed to meet key performance indicators.

15 May 2008

New data reveals impact of deadly human papillomavirus in Latin America, Caribbean

Thirty-three thousand women in Latin America and the Caribbean die each year of preventable cervical cancer, caused by a virus that infects 20 percent of men and women in the region and as many as 30 percent of the youngest women, according to a new study.

12 May 2008

The design of a vaccine against Leishmaniasis

The parasitology team at the "Severo Ochoa" Molecular biology centre (CSIC-UAM) has focused its research efforts on the search for a vaccine capable of activating immunity against the parasite that causes leishmaniasis.

7 May 2008

Mothers less likely to pursue HPV vaccination for youngest daughters

Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.

30 Apr 2008

ImmunoVaccine Technologies patents DepoVax vaccine platform

ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, unveiled today its DepoVax platform, a novel depot vaccine delivery system used to increase the efficacy and strength of vaccines. IVT has filed additional patents to protect the DepoVax concept.

30 Apr 2008

CDC says one in four children are out of compliance with U.S. vaccination guidelines

Your toddler might be improperly vaccinated, even if she's had every immunization the government recommends, according to a new study from the Centers for Disease Control and Prevention.

29 Apr 2008

Southeast Asia the culprit in flu epidemics

According to the World Health Organisation (WHO) each year influenza epidemics are thought to infect between 5 and 15 per cent of the world's population.

17 Apr 2008

CDC issues measles travel warning for Israel

As Americans travel to Israel for the Jewish holiday of Passover, the Centers for Disease Control and Prevention advises all travelers to ensure they are protected from measles before departing, because of a measles outbreak in Israel.

16 Apr 2008

Scientists create monoclonal antibody libraries against avian influenza

An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors of the 2005/2006 "bird flu" outbreak in Turkey.

15 Apr 2008